@chrisstockdads: Watching APRE stock, a small cap biotech in oncology. Targeted treatments in human clinical studies already and a possible Q4 catalyst ahead. #investing #stocks Not financial advice, do your own research. This video was produced on behalf of and sponsored by, Aprea Therapeutics Inc. (Nasdaq: APRE) Stock Dads, LLC was paid one thousand five hundred dollars USD by TDSM Media for this video on behalf of the company.